Видео ютуба по тегу Merck Pharma

Bayer хочет купить подразделение Merck за 14,2 млрд. долларов - corporate
Bayer хочет купить подразделение Merck за 14,2 млрд. долларов - corporate
We visited Merck’s M-Lab facility
We visited Merck’s M-Lab facility
Merck Business Summary
Merck Business Summary
The Secret History of Merck: War, Innovation & Big Pharma #merck #history
The Secret History of Merck: War, Innovation & Big Pharma #merck #history
Merck buys Verona for $10 billion
Merck buys Verona for $10 billion
Continuous Pharmaceutical Manufacturing: Current trends and future possibilities
Continuous Pharmaceutical Manufacturing: Current trends and future possibilities
Merck to Buy Cidara in $9.2B Deal as Patent Deadline Looms
Merck to Buy Cidara in $9.2B Deal as Patent Deadline Looms
Merck CEO: Antiviral pill could make Covid manageable
Merck CEO: Antiviral pill could make Covid manageable
Inside Big Pharma: The Dark Side of Pharmaceutical Giants | FULL DOCUMENTARY
Inside Big Pharma: The Dark Side of Pharmaceutical Giants | FULL DOCUMENTARY
Merck's Magic Sleeping Pills Wake Up Big Pharma
Merck's Magic Sleeping Pills Wake Up Big Pharma
Merck to buy Verona for $10 billion ahead of Keytruda patent expiration
Merck to buy Verona for $10 billion ahead of Keytruda patent expiration
Merck & Co.
Merck & Co.
What to know about Merck's acquisition of Acceleron Pharma
What to know about Merck's acquisition of Acceleron Pharma
Merck Manufacturing Plant Film
Merck Manufacturing Plant Film
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape
Pharma Giant Merck Cancels £1 Billion R&D HQ in London.
Pharma Giant Merck Cancels £1 Billion R&D HQ in London.
Merck to Buy Verona for $10 Billion as Patent Cliff Looms
Merck to Buy Verona for $10 Billion as Patent Cliff Looms
Merck's 5th Pharma Forum designed and executed by Blues N Coppers
Merck's 5th Pharma Forum designed and executed by Blues N Coppers
How This New Biotech Billionaire Outmaneuvered Merck In China
How This New Biotech Billionaire Outmaneuvered Merck In China
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook